Q4 2025 · 13F-HR
Lynx1 Capital Management LPholdings as filed
Filed 2026-02-17 · accession 0001910456-26-000001
$494.0M
Reported value
22
Positions
2025-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $171.5M | 34.7% | 5,404,674 | Common | SHARED |
| G3855L106 | GHRS | GH RESEARCH PLC | $132.2M | 26.8% | 10,406,575 | Common | SHARED |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $92.8M | 18.8% | 8,963,500 | Common | SHARED |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $28.7M | 5.81% | 1,738,750 | Common | SHARED |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $13.6M | 2.74% | 7,098,133 | Common | SHARED |
| 98401F105 | XNCR | XENCOR INC | $10.8M | 2.19% | 705,558 | Common | SHARED |
| N44445109 | IMTX | IMMATICS N.V | $9.7M | 1.96% | 921,950 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $8.0M | 1.62% | 8,019,148 | Common | SHARED |
| 702712209 | PASG | PASSAGE BIO INC | $7.4M | 1.49% | 623,704 | Common | SHARED |
| 500946108 | KRRO | KORRO BIO INC | $5.4M | 1.10% | 677,915 | Common | SHARED |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $4.1M | 0.84% | 993,913 | Common | SHARED |
| 64136E102 | NEUP | NEUPHORIA THERAPEUTICS INC | $3.4M | 0.69% | 875,228 | Common | SHARED |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $2.2M | 0.44% | 79,624 | Common | SHARED |
| 156944100 | CGON | CG ONCOLOGY INC | $1.3M | 0.27% | 31,591 | Common | SHARED |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $799,535 | 0.16% | 12,043 | Common | SHARED |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $652,060 | 0.13% | 69,516 | Common | SHARED |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $531,363 | 0.11% | 51,689 | Common | SHARED |
| 95075A107 | HOWL | WEREWOLF THERAPEUTICS INC | $415,529 | 0.08% | 655,926 | Common | SHARED |
| 56565P103 | MPLT | MAPLIGHT THERAPEUTICS INC | $236,724 | 0.05% | 13,477 | Common | SHARED |
| 37148K209 | — | GENERATION BIO CO | $142,000 | 0.03% | 25,000 | Common | SHARED |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $138,342 | 0.03% | 68,486 | Common | SHARED |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $41,050 | 0.01% | 410,500 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.